Neuroprotection refers to strategies and treatments that preserve the structure and function of neurons exposed to injury, toxins or disease. Research spans acute events such as stroke and traumatic brain injury, as well as chronic conditions like Parkinson’s, Alzheimer’s and multiple sclerosis.

A central theme is oxidative stress. Excess reactive oxygen species damage lipids, proteins and DNA, contributing to neuronal death. Antioxidant approaches include vitamins C and E, glutathione precursors, coenzyme Q10 and polyphenols. Experimental models show these can reduce cell death, limit infarct size after ischemia and improve behavioral outcomes, although translation to clinical benefit remains mixed.

Mitochondria are another key target. Dysfunctional mitochondria trigger energy failure and apoptosis. Agents that stabilize mitochondrial membranes, improve electron transport or enhance mitophagy have shown neuroprotective effects in preclinical models of stroke, epilepsy and neurodegeneration.

Excitotoxicity caused by excessive glutamate signaling is a major mechanism of acute neuronal injury. Modulating NMDA and AMPA receptors, or downstream calcium signaling and nitric oxide production, can reduce damage in experimental systems, but side effects have limited clinical application.

Inflammation within the central nervous system also drives neurodegeneration. Microglia and astrocytes can release both protective and toxic factors. Research explores anti inflammatory drugs, modulation of microglial phenotypes and inhibition of specific cytokines to limit chronic damage while preserving host defense.

Emerging strategies include growth factor delivery, stem cell based tissue repair, enhancement of protein quality control and lifestyle interventions such as exercise and dietary optimization. Overall, most evidence is still preclinical or early clinical, but converging data suggest that effective neuroprotection will likely require combination therapies targeting multiple pathways and early intervention before extensive neuronal loss occurs.